4Aleksic Z, Aleksic A, mitov V, et al. Amiodaron treatment and thyroid autoimmunity markers[J]. Hellenic Journal of Nuclear Medicine,2008,11(2) :105-109. 被引量：1
5Larson SD, Jackson LN, Riall TS, et al. Increased incidence of well-differentiated thyroid cancer associated with Hashimoto thyroiditis and the role of the PI3k/Akt pathway[J]. Journal of The American College of Surgeons, 2007,204 (5) : 764-773. 被引量：1
6Virginia A, LiVolsi. Hashimoto's thyroiditis: Is the epithelium premalignant[J]? International Congress Series, 2007,1299 : 281- 288. 被引量：1
2Davies TF, Weber CM, Wallack P, et al. Restricted heterogeneity and T cell dependence of human thyroid autoantihody immunoglobulin G subclasses. J Clin Endoerinol Metab, 1986, 62:945-949. 被引量：1
3Devey ME, Bleasdale-Barr KM, MeLachlan SM, et al. Serial studies on the affinity and heterogeneity of human autoantibodies to thyroglobulin. Clin Exp Immunol, 1989, 77 : 191-195. 被引量：1
4Weetman AP, Cohen S. The IgG subclass distribution of thyroid autoantibodies. Immunol Lett, 1986, 13:335-341. 被引量：1
5Weetman AP, BLack CM, Cohen SB,et al. Affinity purification of IgG subclasses and the distribution of thyroid auto-antibody reactivity in Hashimoto's thyroiditis. Seand J Immunol, 1989, 30: 73-82. 被引量：1
6McLachlanSM, Feldt-Rasmussen U, Young ET, et al. IgG subclass distribution of thyroid autoantibcdies: a ' fingerprint' of an individual's response to thyroglobulin and thyroid microsomal antigen. Clin Endocrinol, 1987, 26:335-346. 被引量：1
7Davies TF, Platzer M. The suppressor T cell defect in Hashimoto's disease is not thyroid specific. Clin Exp Immunol, 1986, 63:73-79. 被引量：1
8Waldmann H. Manipulation of T cell responses with monoclonal antibodies. Annu Rev Immunol, 1989,7:407-444. 被引量：1
10Mazziotti G, Sorvillo F, Naclerio C, et al. Type-1 response in peripheral CD4 + and CD8 + T cells from patients with Hashimoto's thyroiditis. Eur J Endocrinol, 2003,148:383-388. 被引量：1
